Toll-Like Receptor 4 Expression on Lymphoma Cells Is Critical for Therapeutic Activity of Intratumoral Therapy With Synthetic TLR4 Agonist Glucopyranosyl Lipid A

by Hailing Lu, Alec Betancur, Michael Chen, Jan H. ter Meulen
Published 2020-08-01